Bristol-Myers Extends Cash Tender Offer

NEW YORK (AP) ¿ Drugmaker Bristol-Myers Squibb Co. said Thursday it's extending its cash tender offer to buy up shares of biotech company Medarex Inc. until Aug. 26.

The tender offer originally was set to expire on Aug. 24. All other terms of the deal remain the same.

Bristol-Myers said in July it would pay $16 per share, or $2.1 billion, to acquire Princeton, N.J.-based Medarex. As of Thursday, less than 9 percent of Medarex's outstanding shares had been tendered.

The acquisition would give Bristol-Myers, the maker of blood thinner Plavix, access to drug candidates aimed at immunologic disorders.

The Medarex board has recommended that stockholders tender their shares.

Shares of Bristol-Myers added 6 cents to close at $22.25 Thursday.

Copyright 2009 Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

More from Stocks

Micron CEO: Internet of Things and Data Economy Will Drive Company's Growth

Micron CEO: Internet of Things and Data Economy Will Drive Company's Growth

Tesla Model 3 Delivery Time Falls, but Will It Help the Stock?

Tesla Model 3 Delivery Time Falls, but Will It Help the Stock?

Baidu Stock Plummets After COO Qi Lu Resignation

Baidu Stock Plummets After COO Qi Lu Resignation

18 Top Stocks Hedge Funds Own That Goldman Sachs Thinks Will Keep Outperforming

18 Top Stocks Hedge Funds Own That Goldman Sachs Thinks Will Keep Outperforming

Dow Rises Sharply as U.S.-China Trade Tensions Thaw

Dow Rises Sharply as U.S.-China Trade Tensions Thaw